Thomas A. Hurwich is VP & Controller at AbbVie Inc. (ABBV). They have made 4 open-market trades across 1 company since 2014, most recently 2017-02-28.
CIK 0001563573
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABBV | 69,387 | $20.5M |
Shares reported on the most recent Form 4, priced at the 2017-03-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABBV | SELL | 2017-02-28 | 2017-03-02 | $61.89 | $261K | +4.1% | +3.0% | +4.6% |
| ABBV | SELL | 2016-11-16 | 2016-11-18 | $62.00 | $192K | -2.5% | +2.5% | +1.3% |
| ABBV | SELL | 2016-05-10 | 2016-05-12 | $63.59 | $382K | -2.2% | -3.5% | +7.0% |
| ABBV | SELL | 2016-02-29 | 2016-03-02 | $55.25 | $80K | +2.7% | +3.1% | +13.0% |
| ABBV | SELL · 10b5-1 | 2015-05-19 | 2015-05-21 | $66.00 | $409K | -11.8% | -0.8% | -0.8% |
| ABBV | SELL · 10b5-1 | 2015-02-27 | 2015-03-03 | $60.57 | $72K | -11.8% | -0.8% | -0.8% |
| ABBV | SELL · 10b5-1 | 2014-11-24 | 2014-11-26 | $67.81 | $102K | -11.8% | -0.8% | -0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.